U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118631) titled 'Clinical Study on Emergency Treatment of Cerebral Arteriovenous Malformation Bleeding' on July 30.
Brief Summary: Cerebral arteriovenous malformation (AVM) is the leading cause of brain hemorrhage in young adults, characterized by sudden onset and rapid progression. The hybrid neurosurgical operating room is a diagnostic and therapeutic platform that integrates neurointervention and microneurosurgery, offering advantages such as one-stop rapid treatment and multimodal therapeutic approaches.
This study aims to focus on patients with acute cerebral AVM-related hemorrhage through a multicenter, prospective, registry-based research ap...